资讯

小细胞肺癌(SCLC)治疗棘手,存在侵袭性强、易转移和耐药等问题。研究人员开展多巴胺 D2受体(D2R)激动剂治疗 SCLC 的研究,发现其可抑制肿瘤血管生成,使耐药肿瘤对化疗敏感。这为 SCLC 治疗提供新策略。
SAN FRANCISCO, May 9 (Xinhua) -- A coalition of 15 U.S. states is filing a new lawsuit challenging President Donald Trump's executive order declaring a "national energy emergency," which aims to ...